ACTIVE

EXCELRA BELGIUM

Financial year 2025 · Closed on 31/03/2025

Net result
398,9 k €
+2 362,8 %over 1 year
Gross margin
3 M €
+152,8 %over 1 year
Equity
1,3 M €
+6,1 %over 1 year
Workforce
9,8 ETP
-24,0 %over 1 year

Identity

Source · BCE/KBO

EXCELRA BELGIUM is a Private limited company incorporated in 2017. Its main activity is: Management consultancy activities. Its registered office is in Gent. It employs on average 9,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0673.977.180
Incorporation
07/04/2017
Legal form
Private limited company
Registered office
Oktrooiplein 1 box 201
9000 Gent · FlandreSee on map
Contributed capital
12 500,00 €
Latest accounts
31/03/2025
Average workforce
9,8 ETP
Joint committees (1)
  • 200
Contacts
1 public detail availableLog in to view
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 7 filings

Trend over 7 financial years

20252023202220212020
Income statement
Gross margin3 M €1,2 M €1,8 M €961,8 k €680,4 k €
EBITDA982,8 k €171,6 k €632,3 k €143,1 k €159,3 k €
Operating result-8,2 k €-233,4 k €403,5 k €58,5 k €140,5 k €
Net result398,9 k €-17,6 k €438,4 k €76,4 k €134,2 k €
Balance sheet
Equity1,3 M €1,2 M €1 M €533,6 k €352,3 k €
Total assets1,8 M €1,7 M €1,4 M €952,8 k €695,3 k €
Cash108,1 k €194 k €175,6 k €206,9 k €255,5 k €
Debts521,9 k €455,2 k €397,7 k €406,5 k €343 k €
Other
Workforce9,8 ETP12,9 ETP16,9 ETP11,5 ETP7,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/03/2025

3 active · 10 ended

Active mandates

Excelra B.V. BV

Director · since 10 juin 2024 · 1014.485.485

Represented by Anandbir Brar

Active
BMBK Invest

Director · since 01 janvier 2023 · until 10 juin 2024 · 0744.495.487

Represented by Maarten Braspenning

Active
Ghyssaert Genetics

Director · since 01 janvier 2023 · until 10 juin 2024 · 0719.356.651

Represented by Jan Ghyssaert

Active

Ended mandates

BMBK Invest

Director · since 01 janvier 2023 · 0744.495.487

Represented by Maarten Braspenning

Ended
Ghyssaert Genetics

Director · since 01 janvier 2023 · 0719.356.651

Represented by Jan Ghyssaert

Ended
Katrien Brosens

Director · since 30 juin 2018 · until 20 novembre 2019

Ended
Katrien BROSENS

Director · since 30 juin 2018 · until 28 novembre 2019

Ended

Other companies at this address

Oktrooiplein 1 9000 Gent
CompanyCBE no.
247EVEN● Active
1038.579.592
ABET● Active
0422.301.475
0784.261.034
1038.419.147
A&H Partners● Active
1040.591.155
AIR 4 HOME● Bankrupt
0769.833.867
0876.179.125
ALT INVESTMENTS● Active
1016.281.470
Alt Partners● Active
1016.636.907
ALTRAVIDA● Active
0698.609.143
ASPILON● Active
1020.265.004
ATC Europe● Active
1031.162.755
AVENTA● Active
0660.972.846
BESPAARBETER● Active
1025.039.085
BeursConsult● Active
0733.970.096
BILLIT● Active
0563.846.944
Billit Holding● Active
1030.813.654
Binair● Active
1001.167.385
B. Matters● Active
0789.663.043
B.O.K.E.● Active
1009.566.991

Full financial information

Source · NBB
202520232022202120202019
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202301/07/202201/07/202101/07/202001/07/201901/07/2018
Closing of the financial year31/03/202530/06/202330/06/202230/06/202130/06/202030/06/2019
Length of the financial year21 months12 months12 months12 months12 months12 months
Filing date31/10/202518/01/202430/01/202327/01/202226/02/202128/11/2019
General meeting31/10/202515/11/202330/12/202221/01/202218/02/202128/11/2019
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 7 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/03/202531/10/202531/10/2025DutchPDF
Abridged model30/06/202315/11/202318/01/2024DutchPDF
Abridged model30/06/202230/12/202230/01/2023DutchPDF
Abridged model30/06/202121/01/202227/01/2022DutchPDF
Abridged model30/06/202018/02/202126/02/2021DutchPDF
Abridged model30/06/201928/11/201928/11/2019DutchPDF
Abridged model30/06/201821/11/201820/05/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/03/2025

3 active · 10 ended

Active mandates

Excelra B.V. BV

Director · since 10 juin 2024 · 1014.485.485

Represented by Anandbir Brar

Active
BMBK Invest

Director · since 01 janvier 2023 · until 10 juin 2024 · 0744.495.487

Represented by Maarten Braspenning

Active
Ghyssaert Genetics

Director · since 01 janvier 2023 · until 10 juin 2024 · 0719.356.651

Represented by Jan Ghyssaert

Active

Ended mandates

BMBK Invest

Director · since 01 janvier 2023 · 0744.495.487

Represented by Maarten Braspenning

Ended
Ghyssaert Genetics

Director · since 01 janvier 2023 · 0719.356.651

Represented by Jan Ghyssaert

Ended
Katrien Brosens

Director · since 30 juin 2018 · until 20 novembre 2019

Ended
Katrien BROSENS

Director · since 30 juin 2018 · until 28 novembre 2019

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office30/06/2025
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates11/10/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring17/07/2024
    BENAMING - DOEL - KAPITAAL - AANDELEN - ALGEMENE VERGADERING - BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring13/05/2024
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Other27/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM
    PDF
  • Restructuring22/12/2023
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates15/03/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/12/2019
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025398,9 k €↑
  2. 2025
    Name changeExcelra Belgium
  3. 2023
    Annual accounts 2023-17,6 k €↓
  4. 2022
    Annual accounts 2022438,4 k €↑
  5. 2022
    Name changeBisc Global
  6. 2021
    Annual accounts 202176,4 k €↓
  7. 2020
    Annual accounts 2020134,2 k €↑
  8. 2019
    Annual accounts 201953,8 k €↓
  9. 2018
    Annual accounts 2018145,6 k €
  10. 07/04/2017
    IncorporationPrivate limited company